Despite a stock price increase, the company's financial indi...
Despite a stock price increase, the company's financial indicators are worrisome. Low ROE, flat earnings growth, and a high payout ratio suggest minimal earnings growth. The company's performance disappoints due to low ROE and lack of reinvestment, resulting in poor earnings growth.
Liaoning Chengda Biotechnology Co.,Ltd.'s (SHSE:688739) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment